Ranked #5,410 of 8,699 institutional investors
NVP Associates, LLC
Menlo Park, CA
$259M
US stock portfolio at live prices · today −$1.4M (−0.54%)
Market closed. Prices as of Nov 20, 8:41 AM ET
- Value at quarter end (Q3 2026)
- $282M
- Change from Q2 2026
- −$46.2M (−14.09%)
- Positions
- 6 · 0 new, 1 sold out
- Filed
- Nov 13, 2026
Holdings
Q3 2026 13F, live pricesMBX 44.1%AVLN 25.1%ZBIO 17.8%SNOW 11.9%GROV 1.06%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| MBX MBX Biosciences, Inc. | 2,136,335 | $114M | 44.1% | Unchanged |
| AVLN Avalyn Pharma Inc. | 2,268,404 | $65.1M | 25.1% | Unchanged |
| ZBIO Zenas BioPharma, Inc. | 1,838,482 | $46.0M | 17.8% | Unchanged |
| SNOW Snowflake Inc. | 114,786 | $30.8M | 11.9% | Unchanged |
| GROV Grove Collaborative Holdings, Inc. | 3,225,097 | $2.7M | 1.06% | Unchanged |
| ONDS Ondas Inc. | 15,602 | $66K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| OMDA Omada Health, Inc. | 2,531,000 | $31.6M |